Henry Ji, Ph.D
Henry Ji, Ph.D., co-founded and has served as a director of Sorrento since January 2006, and as its Chief Executive Officer and President since September 2012. Dr. Ji served as Sorrento’s Chief Scientific Officer from November 2008 to September 2012 and as its Interim Chief Executive Officer from April 2011 to September 2012. Dr. Ji… read more »
Brent Ahrens, M.S., M.B.A.
Brent Ahrens joined Canaan in 1999 as a member of the Kauffman Fellows Program. A raconteur extraordinaire, in his work hours, Brent focuses on healthcare investments and has led investments in life sciences companies such as DexCom (DXCM), Revivant (acquired by ZOLL), Peninsula Pharmaceuticals (acquired by JNJ), Cerexa (acquired by FRX), Calixa (acquired by CBST),… read more »
Kenji Hakoda has more than twenty years of management experience in the global chemical trading industry, including 11 years in Korea and Taiwan with a focus on seeking new business development. Mr. Hakoda currently serves as the Pharmaceutical Division Director and Chief Operating Officer for Itochu Chemical Frontier Corporation (“ICF”) in Japan, a member of… read more »
Tien Lee, M.D.
Dr. Lee has over 15 years of experience as a biotechnology innovator and executive who has been integrally involved with the founding or advancement of several biopharmaceutical companies. Dr. Lee joined Nantkwest in 2014 and served as its Chief Strategy Officer until March, 2017. His experience includes therapeutics for immunology, cardiovascular, oncology, neurology, and infectious… read more »
Director, Chief Executive Officer, Scilex Holding
Jaisim Shah is a successful life science leader with significant success in global business development and product commercialization. Jaisim’s track record of success in leading teams in the commercialization of some of today’s most recognized pharmaceutical brands. Innovation, collaboration and patient care has been at the heart and soul of his extensive life science career… read more »
Mahendra G. Shah Ph.D.
Mahendra G. Shah, Ph.D. is a highly successful pharmaceutical entrepreneur and executive who has been at Vivo Capital since March 2010. He was also the founder and Executive Chairman of Semnur Pharmaceuticals(acquired by Scilex Pharmaceuticals) until March 2019. Dr. Shah currently serves as chairman of the board of Essentialis Therapeutics, board member of Biotie Therapies… read more »
Yue Alexander Wu, Ph.D.
Dr. Wu was the co-founder, President, Chief Executive Officer and Chief Scientific Officer of Crown Bioscience International, a leading global drug discovery and development solutions company, which he co-founded in 2006. From 2004 to 2006, Dr. Wu was Chief Business Officer of Starvax International Inc. in Beijing, China, a biotechnology company focusing on oncology and… read more »